VALIDATE-BSI 2019 Posters
VALIDATE-BSI 2019 Conference - Posters
Asst Prof Kiran Afshan
Quaid-i-Azam University, Pakistan
Cutaneous Leishmaniasis in Khyber Pakhtunkhwa, Pakistan (abstract)
Dr Anthony Afum-Adjei Awuah
Kumasi Centre for Collaborative Research (KCCR), Ghana
Why fix when you can prevent; towards TB Vaccines Research in Ghana (abstract)
Dr Federico Carlos Blanco
National Institute of Agricultural Technology (INTA), Argentina
The isolate Mb04-303 induce a proinflammatory innate immune profile and is a potential candidate for an attenuated mutant vaccine against bovine tuberculosis (abstract)
Dr Justice Boakye-Appiah
St George's University of London, UK
Mycolactone based vaccine against Buruli ulcer disease (Section 3 talk; abstract)
Assoc Prof Mary Burtnick
University of Nevada, Reno, USA
Optimization of melioidosis subunit vaccines using Burkholderia thailandensis E555 (abstract)
Dr Panjaporn Chaichana
MORU, Thailand
Identification of protective antibody profiles for vaccine development against melioidosis (abstract)
Assoc Prof Narisara Chantratita
Mahidol University, Thailand
Risk of Burkholderia pseudomallei infection, host immune response and biomarkers for melioidosis (abstract)
Prof Myron Christodoulides
University of Southampton, UK
Protective efficacy of conserved Leishmania hypothetical proteins against visceral leishmaniasis (VALIDATE-funded pump-priming project; abstract)
Dr Fatoumatta Darboe
MRC Unit at LSHTM, The Gambia
TB biomarkers: Diagnosis, prognosis and treatment response monitoring (Session 2 talk; abstract)
Dr Chidchamai Kewcharoenwong
Khon Kaen University, Thailand
Glibenclamide alters cytokine production of primary human monocytes from diabetic individuals against Mycobacterium tuberculosis infection (Session 1 talk; abstract)
Dr Barbara Kronsteiner-Dobramysl
University of Oxford, UK
Metabolic reprogramming of skin microenvironment for improved BCG vaccine efficacy (VALIDATE funded pump-priming project; abstract)
Dr Barbara Kronsteiner-Dobramysl
University of Oxford, UK
Diabetes alters cellular metabolism of T cells: implications for vaccine development (Session 1 talk; abstract)
Asst Prof Ganjana Lertmemongkolchai
Khon Kaen University, Thailand
Metformin-induced suppression of IFN-α expression via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in diabetes mellitus (abstract)
Dr Isadora Lima
FIOCRUZ, Brazil
Canine visceral leishmaniasis: the role of tissue-specific immunity in the progression of disease (Session 1 talk; abstract)
Asst Prof Tufária Mussá
Eduardo Mondlane University, Mozambique
The fusion protein Ag85B-Acr-HBHA (FPI) elicits IFN-γ, IL-2 and TNF-α in conventional T cells of Tuberculosis contacts with latent infection over time (Session 2 talk; abstract)
Dr Rachel Okojie
University of Benin, Nigeria
Comparative study of the immunological and haematological parameters among tuberculosis naive and treated patients in Central Hospital, Benin City, Nigeria (abstract)
Dr Mohamed Osman
University of York, UK
Identification of Leishmania donovani and Mycobacterium tuberculosis- derived proteins on the surface of infected macrophages that are associated with ADCC induction (VALIDATE funded pump-priming project; abstract)
Dr Olayinka Osuolale
Elizade University, Nigeria
Leishmaniasis in patients attending a medical health center in the rural community of Ilara-Mokin, Ondo State, Nigeria (abstract)
Hannah Painter
LSHTM, UK
Development of an ex vivo mycobacterial growth inhibition assay using murine lung cells for tuberculosis vaccine testing (Session 2 talk; abstract)
Dr Deepa Paliwal
University of Reading, UK
Progress in reverse vaccinology approach for bovine TB (Session 3 talk; abstract)
Asst Prof Vijay Kumar Prajapati
Central University of Rajasthan, India
Evaluation of immunogenicity of the engineered multi-epitope subunit vaccine against visceral leishmaniasis infection (abstract)
Dr Eduardo Ramos Sanchez
University of São Paulo, Brazil
Altered expression of microRNAs in infections with cutaneous and visceral strains of Leishmania (Session 2 talk; abstract)
Dr Lok Bahadur Shrestha
BP Koirala Institute of Health Sciences, Nepal
Emerging Clinical Microbiologist looking for research opportunity in TB Vaccinology (abstract)
Dr Lisa Stockdale
University of Oxford, UK
Cytomegalovirus as a correlate of risk for TB? (Session 1 talk; abstract)
Dr Suwarti
Eijkman Oxford Clinical Research Unit (EOCRU), Indonesia
Intranasal boosting regimen of Human Parainfluenza Virus Type 2-Ag85B vaccines induces superior CD4 immune response against Mycobacterium tuberculosis (abstract)
Dr Rachel Tanner
University of Oxford, UK
Characterising the BCG-induced antibody response to inform the design of improved vaccines against M.tuberculosis, M.leprae and M.bovis (VALIDATE Fellowship; abstract)
Dr Julen Tomás Cortázar
University College Dublin, Ireland
Elucidating the mechanisms of protection of the Burkholderia pseudomallei antigen, BpOmpW (abstract)
Chathika Weersuriya
LSHTM, UK
Mathematical modelling of the epidemiological impact, cost-effectiveness and budget impact of novel tuberculosis vaccines on multi-drug resistant tuberculosis (abstract)
